Koss-Olinger Consulting’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$93.8K	Buy	+10,000	New	+$93.8K	0.01%	310
2021 Q3	–	Sell	-8,000	Closed	-$1.3M	–	260
2021 Q2	$1.3M	Hold	8,000	–	–	0.19%	58
2021 Q1	$642K	Buy	+8,000	New	+$642K	0.11%	107